Drug Metabolism and Pharmacokinetics
Online ISSN : 1880-0920
Print ISSN : 1347-4367
ISSN-L : 1347-4367
Regular Articles
Inter-individual Variability of In Vivo CYP2D6 Activity in Different Genotypes
Koji CHIBAMotohiro KATOTakashi ITOToshio SUWAYuichi SUGIYAMA
Author information
JOURNALS FREE ACCESS

2012 Volume 27 Issue 4 Pages 405-413

Details
Abstract

  Cytochrome P450 2D6 (CYP2D6), which has a large number of genetic polymorphisms, is involved in the metabolism of a wide range of substrates. Dextromethorphan (DM) is a well-known probe drug for CYP2D6 and metabolic ratio (MR) is often used to measure the enzyme activity in vivo. Using the literature values of DM MR, we estimated the inter-individual variability of CYP2D6 hepatic intrinsic clearance (CLint,h,2D6) in each genotype by Monte Carlo simulation and found that the homozygote of CYP2D6*1 and the heterozygote of CYP2D6*1 and null alleles had a coefficient of variation (CV) of 43% and 56%, respectively. The variability of homozygotes of CYP2D6*2 and CYP2D6*10 was 63% and 66%, while that of the heterozygotes of CYP2D6*2 and null alleles and CYP2D6*10 and null alleles was 125% and 109%, respectively. Based on the variability and reported frequency of the CYP2D6 genotype in Asians and Caucasians, the inter-individual variability of CLint,h,2D6 of extensive metabolizers was estimated at 60–70%, which provided comparable variability of AUC with the literature values of DM, tolterodine, risperidone and atomoxetine. It is suggested that the produced inter-individual variability of CLint,h,2D6 in each genotype is useful for estimating AUC variability of the CYP2D6 substrates in the regional population.

Information related to the author

This article cannot obtain the latest cited-by information.

© 2012 by The Japanese Society for the Study of Xenobiotics
Previous article Next article
feedback
Top